suggest that dosing frequency is an important factor to consider when selecting a GLP-1RA" Metformin, on the other hand, requires daily oral dosing, which often involves taking it 13 times per day
The manufacturer has every incentive to report favorable results
When a GLP-1 agonist binds its receptor, it can activate two downstream pathways: cAMP (G-protein) pathway: Mediates the metabolic benefits (insulin secretion, appetite suppression, glucose control) Beta-arrestin pathway: Triggers receptor internalization and desensitization, and may contribute to nausea and vomiting Drugs that preferentially activate the cAMP pathway while minimizing beta-arrestin recruitment -- called "biased agonists" -- may maintain efficacy while reducing GI side effects
The medication Ozempic (generic name: semaglutide) has been trending over the past year or so, and has mostly been popularized by celebrities for its weight loss effects
The standard retatrutide dose schedule typically starts at 1 mg weekly for four weeks, then increases to 2 mg, then 4 mg, then 8 mg, and potentially 12 mg
Fewer studies have been carried out with DPP-4 inhibitors